Makers Laboratories Ltd

Makers Laboratories Ltd share price rose by 6.99% to Rs 215.1 after the company's net profit surged by 85.43% to Rs 8.53 crore, while revenue from operations gained 12.72% to Rs 48.21 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.82 lakh crore, easing 5.14%. It has inched up 2.03% over last one week and crept higher by 1.77% in last one month while the market capitalization of Makers Laboratories Ltd has edged up by 13.18% and 35.32% in the same period respectively. Profit before tax (PBT) of Makers Laboratories Ltd stood at Rs 11.55 crore in Q3 FY26, surging by 795.35% year-on-year, and jumping 83.62% quarter-on-quarter. EBITDA came in at Rs 11 crore, rallying 488.08% YoY and expanding by 78.74% sequentially. Total expenses saw a slight increase of 0.89% to Rs 37.27 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 14.58 crore, marginally falling by 2.93% YoY, while employee benefits expense was at Rs 4.0 crore, dipping slightly 1.96% YoY. For the TTM ended FY26, revenue from operations advanced 16.43% to Rs 140.59 crore, while net profit witnessed a sharp fall of 27.96% to Rs 7.86 crore, compared to previous TTM. EBITDA tanked by 476% to Rs 13.03 crore, and PBT dropped 16.85% to Rs 11.15 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 14.29 crore in FY26, as against Rs 4.08 crore in FY25. Makers Laboratories Ltd soared by 72.84% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 7.38% during the same period.

Makers Laboratories Ltd share price declined by 4.24% to Rs 201.05. The Company's net profit surged by 85.43% to Rs 8.53 crore, while revenue from operations increased 12.72% to Rs 48.21 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.73 lakh crore, rising 4.49%. It has marginally improved by 1.84% over last one week and moved up slightly by 1.37% in last one month while the market capitalization of Makers Laboratories Ltd has inched up 5.82% and 21.19% in the same period respectively. Profit before tax (PBT) of Makers Laboratories Ltd stood at Rs 11.55 crore in Q3 FY26, jumping 795.35% year-on-year, and surging by 83.62% quarter-on-quarter. EBITDA came in at Rs 11 crore, rallying 488.08% YoY and expanding by 78.74% sequentially. Total expenses grew marginally by 0.89% to Rs 37.27 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 14.58 crore, easing 2.93% YoY, while employee benefits expense was at Rs 4.0 crore, registering a marginal contraction of 1.96% YoY. For the TTM ended FY26, revenue from operations rose 16.43% to Rs 140.59 crore, while net profit tanked by 27.96% to Rs 7.86 crore, compared to previous TTM. EBITDA saw a sharp decline of 476% to Rs 13.03 crore, and PBT declined 16.85% to Rs 11.15 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 14.29 crore in FY26, as against Rs 4.08 crore in FY25. Makers Laboratories Ltd jumped 58.87% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 8.41% during the same period.

Makers Laboratories Ltd. will hold a board meeting on Wednesday, November 4, 2026, to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Ltd. on October 21, 2026; the trading window for company insiders will remain closed from October 1, 2026, until November 6, 2026.

Makers Laboratories Limited informed the BSE on October 12, 2026, that it is enclosing a certificate from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.

Makers Laboratories Ltd. will close its trading window for insider trading purposes starting October 1, 2026, and continuing until 48 hours after the declaration of the company’s unaudited financial results for the second quarter and half-year ended September 30, 2026, of the financial year 2026-27, according to a filing with the BSE Ltd.

Makers Laboratories Ltd announced via online filing to the BSE Limited on September 1, 2026, that CARE Edge Ratings has reaffirmed the company’s long term bank facilities with a rating of CARE BBB+; Stable, pertaining to long term bank facilities amounting to Rs 8.00 crore; this reaffirmation represents no enhancement, assignment, or withdrawal of ratings, and applies solely to the aforementioned Rs 8.00 crore of long term bank facilities.

Makers Laboratories Ltd share price gained 1.62% to Rs 165.9 after the company's net profit saw a strong growth of 29.21% to Rs 4.6 crore, while revenue from operations increased 19.64% to Rs 42.77 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.84 lakh crore, gaining 5.32%. It has improved by 0.53% over last one week and moving up by 11.64% in last one month while the market capitalization of Makers Laboratories Ltd has edged up by 11.30% and 5.84% in the same period respectively. Profit before tax (PBT) of Makers Laboratories Ltd stood at Rs 6.29 crore in Q2 FY26, surging by 217.68% year-on-year, and expanding by 32.98% quarter-on-quarter. EBITDA came in at Rs 6 crore, rallying 131.75% YoY and jumping 40.80% sequentially. Total expenses increased by 16.86% to Rs 36.94 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 15.02 crore, soaring by 36.79% YoY, while employee benefits expense was at Rs 4.08 crore, ticking higher by 4.35% YoY. For the TTM ended FY26, revenue from operations improved 16.43% to Rs 140.59 crore, while net profit tanked by 27.96% to Rs 7.86 crore, compared to previous TTM. EBITDA saw a sharp decline of 476% to Rs 13.03 crore, and PBT declined 16.85% to Rs 11.15 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 14.29 crore in FY26, as against Rs 4.08 crore in FY25. Makers Laboratories Ltd surged by 12.02% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 1.97% during the same period.

Makers Laboratories will hold a meeting of the Board of Directors of the Company on 7 August 2026.

Makers Laboratories announced that the 41th Annual General Meeting(AGM) of the company will be held on 7 August 2026.

Net profit of Makers Laboratories reported to Rs 1.09 crore in the quarter ended March 2026 as against net loss of Rs 0.05 crore during the previous quarter ended March 2025. Sales rose 5.46% to Rs 35.75 crore in the quarter ended March 2026 as against Rs 33.90 crore during the previous quarter ended March 2025. For the full year,net profit declined 68.62% to Rs 2.35 crore in the year ended March 2026 as against Rs 7.49 crore during the previous year ended March 2025. Sales rose 16.43% to Rs 140.59 crore in the year ended March 2026 as against Rs 120.75 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales35.7533.90 5 140.59120.75 16 OPM %14.749.12 -10.486.94 - PBDT5.873.03 94 15.688.89 76 PBT4.732.13 122 11.154.10 172 NP1.09-0.05 LP 2.357.49 -69 Powered by Capital Market - Live